References
- Kupchan SM, Atland HW. Requirements for tumor-inhibitory activity among benzylisoquinoline alkaloids and related synthetic compounds. J Med Chem 1973; 16: 913–917
- Zeng FD, Shaw DH, Jr, Ogilvie RI. Kinetic disposition and hemodynamic effect of tetrandrine in anesthetized dogs. J Cardiovasc Pharmacol 1985; 7: 1034–1039
- Yu XF, Zou CQ, Lim MB. Observation of the effect of tetrandrine on experimental silicosis of rats. Ecotoxicol Environ Safety 1983; 7: 306–312
- Li Q, Xu Y, Zhow Z. The therapeutic effect of tetrandrine on silicosis. Chin J Tuber Respir Dis 1981; 4: 321–328
- Huang T, Liu Y, Zhao S, Li Y. Changes of acid-soluble collagen from lungs of silicotic rats and tetrandrine-treated silicotic rats. Acta Biochem Biophys Sintca 1981; 13: 61–68
- Liu B, Zou C, Li Y. Studies on the contents of glycosaminoglycans from lungs of silicotic rats and tetrandrine-treated silicotic rats. Ecotoxicol Environ Safety 1983; 7: 323–329
- Kang JH, Lewis DM, Castranova V, Rojanasakul Y, Banks DE, Ma J KH. Inhibitory action of tetrandrine on macrophage production of interleukin-1 (IL-1)-like activity and thymocyte proliferation. Exp Lung Res 1992; 18: 719–733
- Castranova V, Kang JH, Moore MD, Pailes WH, Frazer DG, Schwegler-Berry D. Inhibition of stimulant-induced activation of phagocytic cells with tetrandrine. J Leukocyte Biol 1991; 50: 412–422
- Seow WK, Ferrante A, Li S, Thong YH. Antiphagocytic and antioxidant properties of plant alkaloid tetrandrine. Int Arch Allergy Appl Immunol 1988; 85: 404–409
- Matsuno T, Onta K, Sato E, Nobori K, Inoue B, Utsumi K. Inhibition of metabolic response of polymorphonuclear leukocyte by biscoclaurine alkaloids. Biochem Pharmacol 1987; 36: 1613–1618
- Mo CG, Yu XF, Zou CQ. Studies on the relationship between structure and bioactivity of bisbenzylisoquinoline alkaloids. Wei Sheng Yan Jiu 1982; 4: 118–125
- Castranova V, Kang JH, Ma J KH. Effects of bisbenzylisoquinoline alkaloids on alveolar macrophages: correlation between binding affinity, inhibitory potency, and antifibrotic potential. Toxicol Appl Pharmacol 1991; 108: 242–252
- Lane FC, Mehta JR. In vitro human tumor sensitivity assay using cell counting and sizing. Am Biotech Lab 1990; 8: 12–27
- Phillips HJ. Dye exclusion tests for cell viability. Tissue Culture Methods and Applications, PR Kruse, MK Patterson. Academic Press, New York 1973; 406–408
- Wolff K, Doppen W. Luminometric method. Methods of Enzymatic Analysis, 3rd ed, HU Bergmeyer. Verlag-Chemie, Deerfield Beach, FL 1985; Vol 7: 357–364
- Rao K MK, Castranova V. Phenylmethylsulfonyl fluoride inhibits chemotactic peptide-induced actin polymerization and oxidative burst activity in human neutrophils by an effect unrelated to its antiproteinase activity. Biochim Biophys Acta 1988; 969: 131–138
- Ma J KH, Mo CG, Malanga CJ, Ma J YC, Castranova V. Binding of bisbenzylisoquinoline alkaloids to phosphatidylcholine vesicles and alveolar macrophages: relationship between binding affinity and antifibrogenic potential of these drugs. Exp Lung Res 1991; 17: 1061–1077
- Castranova V, Bowman L, Miles PR. Transmembrane potential and ionic content of rat alveolar macrophages. J Cell Physiol 1979; 101: 471–480
- Liu L, Chen N, Cai G, Li Z, Yang J, Li Y. Studies on the effect of tetrandrine on microtubules, I: biochemical observation and electron microscopy. Ecotoxicol Environ Safety 1988; 15: 142–148
- Chen N, Liu L, Cai G, Yang J, Li Y. Studies on the effects of tetrandrine on microtubules, II: observation with immunofluorescence techniques. Ecotoxicol Environ Safety 1988; 15: 149–152
- Ma J YC, Barger MW, Ma J KH, Castranova V. Effect of tetrandrine on the cytoskeletal control of alveolar macrophage respiratory burst. FASEB J 1992; 6: A1911
- Seow WK, Ferrante A, Goh H, Chalmers AH, Li S, Thong YH. In vitro immunosuppressive properties of the plant alkaloid tetrandrine. Int Arch Allergy Appl Immunol 1988; 85: 410–415